UG · United Guardian Inc
$7.13
-0.20 (-2.73%)
At close · Jul 29
Market Cap
$33.68M
Shares
4.59M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$10.55M
-13.4%
FY2025
Net Income
$2.11M
-35.2%
FY2025
Gross Margin
48.75%
-4.3pp
FY2025
Operating Margin
21.27%
-8.7pp
FY2025
Operating Cash Flow
$1.97M
-43.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $10.94M | $10.55M | $12.18M | $10.89M | $12.7M | $13.93M | $10.99M | $13.6K | $13.45M | $12.97M | $10.78M | $14.01M | $13.45M | $15.42M | $13.83M | $14.34M | $13.72M | |
| $5.73M | $5.4M | $5.72M | $5.48M | $6M | $5.75M | $4.87M | $5.66M | $5.34M | $5.3M | $4.88M | $5.2M | $5.32M | $5.61M | $5.22M | $5.65M | $5.25M | |
| $5.21M | $5.14M | $6.46M | $5.41M | $6.7M | $8.18M | $6.11M | -$5.64M | $8.1M | $7.67M | $5.89M | $8.8M | $8.13M | $9.81M | $8.61M | $8.69M | $8.47M | |
| — | 48.75% | 53.03% | 49.66% | 52.78% | 58.74% | 55.65% | -41500.99% | 60.26% | 59.12% | 54.69% | 62.86% | 60.46% | 63.61% | 62.25% | 60.59% | 61.74% | |
| $464.27K | $463.64K | $456.78K | $463.99K | $490.77K | $478.64K | $451.21K | $397.39K | $399.52K | $646.08K | $651.83K | $648.21K | $730.41K | $717K | $693K | $637K | — | |
| — | $108.2K | $95.89K | $105.68K | $135.4K | $145.98K | $165.26K | $175.81K | $191.94K | $200.68K | $187.04K | $173.48K | $181.19K | $189.73K | $254.44K | $255.58K | $229.78K | |
| $2.11M | — | — | — | — | — | — | — | $2.12M | $1.79M | $1.85M | $1.86M | $1.91M | $2.5M | $2.51M | $2.55M | $2.57M | |
| $8.66M | $8.3M | $8.54M | $8.02M | $8.66M | $8.26M | $7.35M | $8.2M | $7.87M | $7.73M | $7.39M | $7.71M | $7.96M | $8.12M | $7.73M | $8.2M | $8.67M | |
| $2.27M | $2.24M | $3.65M | $2.86M | $4.04M | $5.67M | $3.64M | $5.4M | $5.58M | $5.24M | $3.39M | $6.29M | $5.49M | $7.3M | $6.1M | $6.14M | $5.06M | |
| — | 21.27% | 29.94% | 26.3% | 31.79% | 40.68% | 33.1% | 39678.89% | 41.5% | 40.37% | 31.45% | 44.93% | 40.83% | 47.36% | 44.11% | 42.79% | 36.86% | |
| — | $2.35M | $3.74M | $2.97M | $4.17M | $5.81M | $3.8M | $5.57M | $5.77M | $5.44M | $3.58M | $6.47M | $5.67M | $7.49M | $6.35M | $6.39M | $5.29M | |
| $693.32K | $399.67K | $461.67K | $387.75K | -$809.55K | $210.84K | $524.83K | $634.41K | -$113.99K | $315.17K | $306.51K | $331.83K | $264K | $1.33M | $828.21K | $736.09K | $455.79K | |
| $39.75K | $34.36K | $26.99K | $81.1K | -$1.05M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $2.97M | $2.64M | $4.11M | $3.25M | $3.23M | $5.88M | $4.16M | $6.03M | $5.47M | $5.55M | $3.7M | $6.63M | $5.75M | $8.63M | $6.93M | $6.87M | $5.51M | |
| $604.45K | $537.28K | $857.58K | $669.41K | $658.17K | $1.22M | $856.02K | $1.27M | $1.11M | $1.71M | $1.11M | $2.02M | $1.7M | $2.73M | $2.1M | $2.16M | $1.71M | |
| $2.36M | $2.11M | $3.25M | $2.58M | $2.57M | $4.66M | $3.3M | $4.76M | $4.35M | $3.84M | $2.58M | $4.61M | $4.05M | $5.9M | $4.83M | $4.72M | $3.8M | |
| — | 19.97% | 26.69% | 23.71% | 20.23% | 33.44% | 30.08% | 35014.94% | 32.37% | 29.64% | 23.95% | 32.89% | 30.12% | 38.29% | 34.94% | 32.89% | 27.69% | |
| — | — | — | — | — | — | — | — | $4.35M | $4.1M | $2.68M | $4.42M | $4.18M | $5.86M | $4.98M | $4.74M | — | |
| USD/shares | — | $0.46 | $0.71 | $0.56 | $0.56 | $1.01 | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.6M | 4.6M | 4.6M | 4.6M | — |
| shares | — | — | — | — | — | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.59M | 4.6M | 4.6M | 4.6M | 4.6M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2025: $3.76M in buybacks, $64.93M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 25.67×
Peer medians compare against the 9 similar-size Household & Personal Products companies (of 28 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $8,141,533 | $10,175,926 | $8,601,205 | $9,537,124 | $11,159,341 | $8,796,221 |
| Non Us | $2,403,935 | $2,006,045 | $2,283,949 | $3,161,379 | $2,770,288 | $2,189,860 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Pharmaceuticals | $5,427,842 | $4,715,145 | $4,950,594 | $4,943,605 | $4,735,324 | $4,519,052 |
| Cosmetic Ingredients | $3,006,522 | $5,438,262 | $4,132,334 | $5,167,909 | $6,872,714 | $4,274,586 |
| Medical Lubricants | $2,111,104 | $2,028,564 | $1,750,632 | $2,470,163 | $2,171,204 | — |
| Industrial and Other | — | — | $51,594 | $116,826 | $150,387 | $139,482 |
| Medical Product | — | — | — | — | — | $2,052,961 |